SANJAY DESHPANDE to Neoplasm Recurrence, Local
This is a "connection" page, showing publications SANJAY DESHPANDE has written about Neoplasm Recurrence, Local.
Connection Strength
0.132
-
Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysis. Haematologica. 2019 05; 104(5):e211-e214.
Score: 0.100
-
Molecular determinants of outcomes in relapsed or refractory mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trial. Leukemia. 2022 10; 36(10):2479-2487.
Score: 0.032